ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

COG Cambridge Cognition Holdings Plc

56.20
1.20 (2.18%)
28 Mar 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cambridge Cognition Holdings Plc LSE:COG London Ordinary Share GB00B8DV9647 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  1.20 2.18% 56.20 54.00 55.00 54.50 54.50 54.50 21,504 16:35:07
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 12.61M -409k -0.0117 -46.58 18.99M

Cambridge Cognition Holdings PLC Result of AGM & Board Change (2667G)

25/05/2017 2:22pm

UK Regulatory


Cambridge Cognition (LSE:COG)
Historical Stock Chart


From Mar 2019 to Mar 2024

Click Here for more Cambridge Cognition Charts.

TIDMCOG

RNS Number : 2667G

Cambridge Cognition Holdings PLC

25 May 2017

25(th) May 2017

Cambridge Cognition Holdings Plc

('Cambridge Cognition' or the 'Company')

Result of AGM & Board Change

The neuroscience company Cambridge Cognition Holdings plc (AIM: COG), which develops and markets products and near patient technologies for cognitive assessment in clinical trials and healthcare applications held its Annual General Meeting today at 10.00am at the registered office of the Company, Tunbridge Court, Tunbridge Lane, Bottisham, Cambridge, CB25 9TU. All resolutions were duly passed.

During the meeting the Company announced that Dr. Andrew (Andy) Blackwell, formerly CSO and currently Non-Executive Director, will be standing down from the board with effect from 1(st) July 2017.

Non-Executive Chairman at Cambridge Cognition, Michael Lewis commented: "We would like to thank Andy for his major contribution to the development of Cambridge Cognition. He has played a key role in shaping the scientific foundation and reputation of the Company and in building a new science leadership team. The Company is entering a new phase in its development as new wearable and digital health technologies are brought to market and we will seek a new Board member to continue Andy's work in this next stage in the Company's development."

Enquiries:

 
 Cambridge Cognition Holdings 
  plc 
 Steven Powell, Chief Executive            Tel: 01223 810 
  Officer                                             700 
 Noah Konig, Director of Product         press@camcog.com 
  Marketing and Communications 
 
 finnCap Ltd (Nomad & Joint Broker)         Tel: 020 7220 
                                                     0500 
 Geoff Nash / Simon Hicks             (Corporate Finance) 
 Alice Lane                           (Corporate Broking) 
 Dowgate Capital Stockbrokers               Tel: 020 3903 
  Limited (Joint Broker)                             7715 
 David Poutney/ James Serjeant        (Corporate Broking) 
 
 
 

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGMMGZKFKLGNZM

(END) Dow Jones Newswires

May 25, 2017 09:22 ET (13:22 GMT)

1 Year Cambridge Cognition Chart

1 Year Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

1 Month Cambridge Cognition Chart

Your Recent History

Delayed Upgrade Clock